Quinagolide
From Wikipedia, the free encyclopedia
![]() |
|
Clinical data | |
---|---|
Trade names | Norprolac |
AHFS/Drugs.com | International Drug Names |
Routes of administration |
Oral |
ATC code | G02CB04 (WHO) |
Legal status | |
Legal status |
|
Identifiers | |
|
|
CAS Number | 87056-78-8 ![]() |
PubChem (CID) | 55645 |
ChemSpider | 2343034 ![]() |
UNII | 80Q9QWN15M ![]() |
KEGG | D07217 ![]() |
ChEMBL | CHEMBL290962 ![]() |
Chemical and physical data | |
Formula | C20H33N3O3S |
Molar mass | 395.56 g/mol |
|
|
![]() ![]() |
Quinagolide (INN, BAN) (brand name Norprolac) is a selective D2 receptor agonist that is used to reduce elevated levels of prolactin (hyperprolactinemia).[1] It has also been found to be effective in the treatment of breast pain.[2]
See also[edit]
References[edit]
- ^ Antonella Di Sarno; Maria Luisa Landi; Paolo Marzullo; Carolina Di Somma; Rosario Pivonello; Gaetana Cerbone; Gaetano Lombardi; Annamaria Colao (July 2000). "The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas". Clinical Endocrinology. 53 (1): 53–60. doi:10.1046/j.1365-2265.2000.01016.x. PMID 10931080.
- ^ Alfonso M Pluchinotta (20 April 2015). The Outpatient Breast Clinic: Aiming at Best Practice. Springer. pp. 167–. ISBN 978-3-319-15907-2.
![]() |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |